BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38129891)

  • 1. Succinate-induced macrophage polarization and RBP4 secretion promote vascular sprouting in ocular neovascularization.
    Shen T; Lin R; Hu C; Yu D; Ren C; Li T; Zhu M; Wan Z; Su T; Wu Y; Cai W; Yu J
    J Neuroinflammation; 2023 Dec; 20(1):308. PubMed ID: 38129891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization.
    Liu X; Guo A; Tu Y; Li W; Li L; Liu W; Ju Y; Zhou Y; Sang A; Zhu M
    Cell Death Dis; 2020 Nov; 11(11):1016. PubMed ID: 33247124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
    Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
    Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
    Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization.
    Zhu Y; Tan W; Demetriades AM; Cai Y; Gao Y; Sui A; Lu Q; Shen X; Jiang C; Xie B; Sun X
    Immunology; 2016 Apr; 147(4):414-28. PubMed ID: 26694999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α signaling regulates RUNX1 function in endothelial cells.
    Whitmore HAB; Amarnani D; O'Hare M; Delgado-Tirado S; Gonzalez-Buendia L; An M; Pedron J; Bushweller JH; Arboleda-Velasquez JF; Kim LA
    FASEB J; 2021 Feb; 35(2):e21155. PubMed ID: 33135824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin attenuates choroidal neovascularization by regulating macrophage/microglia polarization via inhibition of RhoA/ROCK signaling pathway.
    Xu Y; Cui K; Li J; Tang X; Lin J; Lu X; Huang R; Yang B; Shi Y; Ye D; Huang J; Yu S; Liang X
    J Pineal Res; 2020 Aug; 69(1):e12660. PubMed ID: 32323368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoB antibody alters retinal vascularization in models of murine retinopathy.
    Almonte-Baldonado R; Bravo-Nuevo A; Gerald D; Benjamin LE; Prendergast GC; Laury-Kleintop LD
    J Cell Biochem; 2019 Jun; 120(6):9381-9391. PubMed ID: 30536763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of myeloid PFKFB3-driven glycolysis protects mice from choroidal neovascularization.
    Liu Z; Mao X; Yang Q; Zhang X; Xu J; Ma Q; Zhou Y; Da Q; Cai Y; Sopeyin A; Dong Z; Hong M; Caldwell RB; Sodhi A; Huo Y
    Br J Pharmacol; 2022 Nov; 179(22):5109-5131. PubMed ID: 35830274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial TWIST1 promotes pathological ocular angiogenesis.
    Li J; Liu CH; Sun Y; Gong Y; Fu Z; Evans LP; Tian KT; Juan AM; Hurst CG; Mammoto A; Chen J
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8267-77. PubMed ID: 25414194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The P300/XBP1s/Herpud1 axis promotes macrophage M2 polarization and the development of choroidal neovascularization.
    Li W; Wang Y; Zhu L; Du S; Mao J; Wang Y; Wang S; Bo Q; Tu Y; Yi Q
    J Cell Mol Med; 2021 Jul; 25(14):6709-6720. PubMed ID: 34057287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF1/CSF1R-mediated Crosstalk Between Choroidal Vascular Endothelial Cells and Macrophages Promotes Choroidal Neovascularization.
    Zhou Y; Zeng J; Tu Y; Li L; Du S; Zhu L; Cang X; Lu J; Zhu M; Liu X
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):37. PubMed ID: 33764399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.
    Huang H; Shen J; Vinores SA
    PLoS One; 2011; 6(6):e21411. PubMed ID: 21731737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.
    Du H; Sun X; Guma M; Luo J; Ouyang H; Zhang X; Zeng J; Quach J; Nguyen DH; Shaw PX; Karin M; Zhang K
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2377-82. PubMed ID: 23341606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of αA-crystallin inhibits ocular neovascularization.
    Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
    Gong Y; Fu Z; Edin ML; Liu CH; Wang Z; Shao Z; Fredrick TW; Saba NJ; Morss PC; Burnim SB; Meng SS; Lih FB; Lee KS; Moran EP; SanGiovanni JP; Hellström A; Hammock BD; Zeldin DC; Smith LE
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1919-27. PubMed ID: 27417579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.
    Darche M; Cossutta M; Caruana L; Houppe C; Gilles ME; Habert D; Guilloneau X; Vignaud L; Paques M; Courty J; Cascone I
    FASEB J; 2020 Apr; 34(4):5851-5862. PubMed ID: 32141122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.